The Boston Consulting Group (BCG) recently released the latest report "Winning the ever-changing Chinese medical technology market", pointing out that China's medical technology market will maintain a compound annual growth rate of 14% between 2013 and 2020, and by 2020, the market size It will increase to 55 billion US dollars, becoming the world's second largest market. The report pointed out that under the impetus of medical reform, the entire Chinese medical system has undergone a major transformation. The main trends include: regulatory policies encourage enterprises to actively innovate and establish a level playing field; price pressures are increasing; medical insurance reimbursement coverage continues to expand, hospital budgets are tightening; hospital patterns are changing, and small hospitals are taking on greater The responsibility and so on. One of the report's authors, BBC partner Luo Ying, said, “Today's Chinese medical technology industry is very different from a decade ago, and this market will undergo tremendous changes in the next decade.†The report reveals The three most important trends in the future of China's medical technology market: First, the scale of the mid-end market is expanding and its importance is increasingly apparent. Second, local companies continue to rise. Third, the sales and distribution mechanism of medical technology products will change. According to the report, China's medical reform has brought valuable opportunities and severe challenges to the medical technology industry. Multinational companies and local enterprises urgently need to take effective and effective measures to better grasp this growth opportunity. Nosiheptide Feed Additives,Nosiheptide Antibiotics,Nosiheptide Growth Prompter,Nosiheptide Poultry Shandong Shengli Bioengineering Co., Ltd , https://www.shenglipharm.com